Veterinary Medicines

NEMOVAC LYOPHILISATE FOR OCULONASAL SUSPENSION/USE IN DRINKING WATER

Authorised
  • Turkey rhinotracheitis virus, strain PL21, Live
Download as PDF

Product identification

Medicine name:
NEMOVAC LYOPHILISATE FOR OCULONASAL SUSPENSION/USE IN DRINKING WATER
NEMOVAC
Active substance:
  • Turkey rhinotracheitis virus, strain PL21, Live
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
  • Chicken (broiler)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain PL21, Live
    2.30
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • Box of one 1000-dose bottle
  • Box of ten 5000-dose bottles
  • Box of one 5000-dose bottles
  • Box of ten 2000-dose bottles
  • Box of one 2000-dose bottle
  • Box of ten1000-dose bottle,

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.04331.01.1
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0353/001
Concerned member states:
  • Austria
  • Germany
  • Greece
  • Ireland
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 23/06/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 23/06/2023
Download